Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermal-epidermal engineered skin substitutes

Pigment Cell Melanoma Res. 2017 Jan;30(6):531-540. doi: 10.1111/pcmr.12609. Epub 2017 Oct 19.

Abstract

Autologous engineered skin substitutes (ESS) containing melanocytes (hM) may restore pigmentation and photoprotection after grafting to full-thickness skin wounds. In this study, normal hM were isolated from discard skin, propagated with or without tyrosinase inhibitors, cryopreserved, recovered into culture, and added to ESS (ESS-P) before transplantation. ESS-P were incubated in either UCMC160/161 or UCDM1 medium, scored for hM densities, and grafted to mice. The results showed that sufficient hM can be propagated to expand donor tissue by 100-fold; incubation of hM in tyrosinase inhibitors reduced pigment levels but did not change hM recovery after cryopreservation; hM densities in ESS-P were greater after incubation in UCDM1 than UCMC160 medium; hM were localized to the dermal-epidermal junction of ESS-P; and UCDM1 medium promoted earlier pigment distribution and density. These results indicate that hM can be incorporated into ESS-P efficiently to restore cutaneous pigmentation and UV photoprotection after full-thickness skin loss conditions.

Keywords: cultured human melanocytes; engineered skin substitutes; photoprotection; skin pigmentation; wound closure.

MeSH terms

  • Administration, Topical
  • Animals
  • Cell Count
  • Cell Separation
  • Cryopreservation
  • Dermis / physiology*
  • Enzyme Inhibitors / pharmacology
  • Epidermis / physiology*
  • Humans
  • Inflammation / pathology
  • Melanocytes / drug effects
  • Melanocytes / transplantation*
  • Mice, SCID
  • Monophenol Monooxygenase / antagonists & inhibitors
  • Monophenol Monooxygenase / metabolism
  • Skin Pigmentation* / drug effects
  • Skin, Artificial*
  • Tissue Engineering*

Substances

  • Enzyme Inhibitors
  • Monophenol Monooxygenase